Startseite Crystal structure of (E)-(3-(2,4-dichlorophenyl)acryloyl)ferrocene, C19H14Cl2FeO
Artikel Open Access

Crystal structure of (E)-(3-(2,4-dichlorophenyl)acryloyl)ferrocene, C19H14Cl2FeO

  • Shuang Zhang , Jie Gao , Juanjuan Wen , Yanrong Gao und Bin Liu ORCID logo EMAIL logo
Veröffentlicht/Copyright: 15. April 2025

Abstract

C19H14Cl2FeO, monoclinic, P21/n (no. 14), a = 7.3383(5) Å, b = 10.1441(6) Å, c = 21.4807(12) Å, α = 90 Å, β = 91.649(2) Å, γ = 90 Å, V = 1,598.37(17) Å3, Z = 4, Rgt(F) = 0.0443 wRref(F2) = 0.1132, T = 183 K.

The molecular structure is shown in the figure. Table 1 contains the crystallographic data. The list of the atoms including atomic coordinates and displacement parameters can be found in the cif-file attached to this article.

CCDC no.: 2425389

1 Source of materials

The furan-2-carbaldehyde (3.83 g, 22.0 mmol), acetylferrocene (2.28 g, 10.0 mmol) and KOH (0.67 g, 12.0 mmol) were added to the mortar. After stirring well, the reaction mixture was grind for 20 min, until the TLC indicated the reaction was completed, then diluted with water and filtered. The solid was collected and washed with water, and dried overnight under vacuum. The crude product was further purified by flash silica chromatography. For crystal growth, the crude product was dissolved in a minimal amount of hot ethanol and slowly cooled to room temperature (Table 1).

Table 1:

Data collection and handling.

Crystal: Red block
Size: 0.15 × 0.11 × 0.07 mm
Wavelength: Mo Kα radiation (0.71073 Å)
μ: 1.28 mm−1
Diffractometer, scan mode: Bruker APEX2, φ and ω scans
θmax, completeness: 26.4°, 100 %
N(hkl)measured, N(hkl)unique, Rint: 9,517, 3,258, 0.067
Criterion for Iobs, N(hkl)gt: Iobs > 2 σ(Iobs), 2,630
N(param)refined: 208
Programs: Bruker, 1 SHELX, 2 , 3 Olex2 4

2 Experimental details

The crystal structure was determined with the SHELXT program. 2 The initial solution was further refined through the SHELXL program, 3 which was implemented within the Olex2 software package. 4 Non-hydrogen atoms were refined anisotropically, while the hydrogen atoms were positioned at their idealized locations based on standard geometrical constraints.

3 Comment

Ferrocene, a typical organometallic compound, has long been a subject of extensive study due to its structural features and applications in several fields. 5 Crystallographic investigations of ferrocene and its derivatives provide detailed insights into packing, intermolecular interactions, and the influence of substituent groups on their physical properties. 6 , 7 , 8 , 9 , 10 , 11 The study of (E)- (3-(2,4-dichlorophenyl)acryloyl)ferrocene, a derivative of ferrocene, aims to explore the impact of the acrylate and dichlorophenyl substituents on the molecular arrangement and crystallization behavior, and contributes to the growing knowledge regarding the crystallography of ferrocene derivatives and their structure-property relationships.

The core of the molecule consists of a ferrocene unit, where an iron (Fe) atom is sandwiched between two cyclopentadienyl anions (C5H5). The Fe–C bond lengths range from 3.04 Å to 3.06 Å, and the C–C bond lengths fall within the same range of 3.04 Å to 3.06 Å. The dihedral angle between the two C5H5 rings is 1.9 Å, consistent with previously reported similar structures. 12 , 13 , 14 , 15 , 16 The acrylate group is attached to the ferrocene core at position 3, with the (E)-configuration of the double bond. The C9–C11 bond length is 1.472(5) Å. The 2,4-dichlorophenyl ring is positioned adjacent to the acrylate group, with chlorine (Cl) atoms at the 2 and 4 positions. The C17–Cl2 bond length is 1.741(4) C5H5, and the C15–Cl1 bond length is 1.742(4) Å. The phenyl ring is not coplanar with the C5H5 ring, resulting in a torsion with a dihedral angle of 34.1°.

In the solid state, the molecules pack together via π-π stacking interactions between the aromatic phenyl rings, particularly between the 2,4-dichlorophenyl ring and neighboring phenyl groups from adjacent molecules. These π-π interactions stabilize the crystal structure and contribute to its high packing efficiency.


Corresponding author: Bin Liu, Xianyang Key Laboratory of Molecular Imaging and Drug Synthesis, School of Pharmacy, Shaanxi Institute of International Trade & Commerce, Xianyang, Shaanxi, China, E-mail:

Acknowledgments

This work was financially supported by the projects of Social Development in Shaanxi Province Science and Technology Department (2023–YBSF-036), the 2023 research and development project of the Xianyang Science and Technology Bureau (L2023–ZDYF–SF-030), Key Laboratory of Molecular Imaging and Drug Synthesis of Xianyang city (2021QXNL–PT-0008), School-level Scientific and Technological Innovation Team for Design, Synthesis and Structural Modification of Drug Molecules (2024KCTD04).

References

1. Bruker. SAINT, APEX2 and SADABS; Bruker AXS Inc.: Madison, WI, USA, 2012.Suche in Google Scholar

2. Sheldrick, G. M. SHELXT – Integrated Space-Group and Crystal-Structure Determination. Acta Crystallogr. 2015, A71, 3–8; https://doi.org/10.1107/s2053273314026370.Suche in Google Scholar PubMed PubMed Central

3. Sheldrick, G. M. Crystal Structure Refinement with SHELXL. Acta Crystallogr. 2015, C71, 3–8; https://doi.org/10.1107/s2053229614024218.Suche in Google Scholar

4. Dolomanov, O. V.; Bourhis, L. J.; Gildea, R. J.; Howard, J. A.; Puschmann, H. OLEX2: a Complete Structure Solution, Refinement and Analysis Program. J. appl. crystallogr. 2009, 42, 339–341; https://doi.org/10.1107/s0021889808042726.Suche in Google Scholar

5. Štěpnička, P. Forever Young: the First Seventy Years of Ferrocene. Dalton Trans. 2022, 51, 8085–8102; https://doi.org/10.1039/d2dt00903j.Suche in Google Scholar PubMed

6. Artigas, V.; González, D.; Fuentealba, M. Syntheses, Characterisation and Crystal Structures of Ferrocenyl β-diketones and Their Schiff Base NNO Ligand Derivatives with 2-picolylamine. J. Mol. Struct. 2017, 1129, 325–332; https://doi.org/10.1016/j.molstruc.2016.09.009.Suche in Google Scholar

7. Shi, Y. -C.; Yang, H. -M.; Shen, W. -B.; Yan, C. -G.; Hu, X. -Y. Syntheses and Crystal Structures of Ferrocene-Containing Enaminones and Their Copper Complexes. Polyhedron 2004, 23, 15–21; https://doi.org/10.1016/j.poly.2003.08.017.Suche in Google Scholar

8. Tang, W.; Gao, Y.; Tong, H.; Xu, X.; Zhu, Z.; Liu, B. Green Synthesis of Ferrocenyl Chalcones against Triple Negative Breast Cancer. J. Organomet. Chem. 2023, 989, 122640; https://doi.org/10.1016/j.jorganchem.2023.122640.Suche in Google Scholar

9. Delavaux-Nicot, B.; Maynadié, J.; Lavabre, D.; Lepetit, C.; Donnadieu, B. The First X-Ray Characterized Monosubstituted Ferrocenyl Azacrown Chalcone: Focus on its Calcium Interaction/Electrochemical Detection Studies. Eur. J. Inorg. Chem. 2005, 2005, 2493–2505; https://doi.org/10.1002/ejic.200400781.Suche in Google Scholar

10. Allison, M.; Caramés-Méndez, P.; Pask, C. M.; Phillips, R. M.; Lord, R. M.; McGowan, P. C. Bis(bipyridine)Ruthenium(II) Ferrocenyl β–Diketonate Complexes: Exhibiting Nanomolar Potency against Human Cancer Cell Lines. Chem.-Eur. J. 2021, 27, 3737–3744; https://doi.org/10.1002/chem.202004024.Suche in Google Scholar PubMed

11. Novoa, N.; Roisnel, T.; Dorcet, V.; Hamon, J. -R.; Carrillo, D.; Manzur, C.; Robin-Le Guen, F.; Cabon, N. Anisyl and Ferrocenyl Adducts of Methylenepyran-Containing β-diketone: Synthesis, Spectral, Structural, and Redox Properties. J. Organomet. Chem. 2014, 762, 19–28; https://doi.org/10.1016/j.jorganchem.2014.03.029.Suche in Google Scholar

12. Long, S. -J.; Liu, X. -L.; Liu, Y. -H. (E)-1–Ferrocenyl-3-(4-methoxyphenyl) prop-2-en-1-one. Acta Crystallogr.Sec. E 2008, 64, m1164; https://doi.org/10.1107/s1600536808025518.Suche in Google Scholar

13. Otano Vega, M. R.; Rivero, K. I.; Montes Gonzalez, I. (E)-1–Ferrocenyl-3- (2-Methoxyphenyl)prop-2-en-1-one. Acta Crystallogr. Sec. E 2014, 70, m108–m109; https://doi.org/10.1107/s1600536814003912.Suche in Google Scholar PubMed PubMed Central

14. Ding, F.; Xu, X.; Zhu, Z.; Tong, H.; Tang, W. Crystal Structure of (E)-(3-(thiophen-2-yl)acryloyl)ferrocene. Z. Kristallogr.- N. Cryst. Struct. 2025, 240, 295–297; https://doi.org/10.1515/ncrs-2024-0475.Suche in Google Scholar

15. Zhang, J.; Hu, X.; Liu, X.; He, Y. The crystal structure of (E) -1-ferrocenyl-3-(4-isopropylphenyl)prop-2-en-1-one, C–H22FeO. Z. Kristallogr. - N. Cryst. Struct. 2022, 237, 437–439; https://doi.org/10.1515/ncrs-2022-0063.Suche in Google Scholar

16. Wang, Y.; Zheng, H.; Zhang, K.; Li, X.; Liu, B. Crystal Structure of (E)-(3-(3-methylthiophen-2-yl)acryloyl)ferrocene. Z. Kristallogr. - N. Cryst. Struct. 2025, 240, 337–339. https://doi.org/10.1515/ncrs-2025-0004.Suche in Google Scholar

Received: 2025-03-07
Accepted: 2025-04-02
Published Online: 2025-04-15
Published in Print: 2025-06-26

© 2025 the author(s), published by De Gruyter, Berlin/Boston

This work is licensed under the Creative Commons Attribution 4.0 International License.

Artikel in diesem Heft

  1. Frontmatter
  2. New Crystal Structures
  3. Crystal structure of 5,5′-bis(2,4,6-trinitrophenyl)-2,2′-bi(1,3,4-oxadiazole), C16H4N10O14
  4. Crystal structure of catena-poly[(μ3-4,4′-oxydibenzoato- κ5 O,O: O,O:O)-bis(2,4,6-tri(3-pyridine)-1,3,5-triazine-κ1 N)cadmium(II)], C50H32CdN12O5
  5. The crystal structure of 1,4-diazepane-1,4-diium potassium trinitrate, C5H14KN5O9
  6. The crystal structure of benzyl 2,2,5,5-tetramethylthiazolidine-4-carboxylate, C15H21NO2S
  7. Crystal structure of 2-hydroxyethyl-triphenylphosphonium tetracyanidoborate, C24H20BN4OP
  8. The crystal structure of 1-methyl-3-(N-methylnitrous amide–N-methylene) imidazolidine-2,4,5-trione
  9. Crystal structure of N-((3-cyano-1-(2,6-dichloro-4-(trifluoromethyl)phenyl)-4-(2,2,2-trifluoroacetyl)-1H-pyrazol-5-yl)carbamoyl)-2,6-difluorobenzamide, C20H7Cl2F8N5O3S
  10. Crystal structure of 5-(2,2-difluoropropyl)-5-methylbenzo[4,5]imidazo[2,1-a] isoquinolin-6(5H)-one, C20H18F2N2O
  11. The crystal structure of N′,N″-[1,2-bis(4-chlorophenyl)ethane-1,2-diylidene]bis(furan-2- carbohydrazide), C24H16Cl2N4O4
  12. Crystal structure of [(4-bromobenzyl)triphenylphosphonium] tetrabromoantimony(III), [C25H21BrP]+[SbBr4]
  13. Crystal structure of [(4-bromobenzyl)triphenylphosphonium] tetrabromidoindium(III), [C25H21BrP]+[InBr4]
  14. The crystal structure of 4-carboxy-2-oxobutan-1-aminium chloride, C5H10ClNO3
  15. Crystal structure of (4-(4-chlorophenyl)-1H-pyrrole-3-carbonyl)ferrocene, C21H16ClFeNO
  16. The crystal structure of dichlorido(η6-p-cymene)(triphenylarsine)ruthenium(II), C28H29AsCl2Ru
  17. Crystal structure of (Z)-2-hydroxy-N′-(1-(o-tolyl)ethylidene)benzohydrazide, C16H16N2O2
  18. The crystal structure of 10-(1-bromoethyl)-14-(bromomethyl)dibenzo[a, c]acridine, C24H17NBr2
  19. Synthesis and crystal structure of 6-methoxy-7-[(4-methoxyphenyl)methoxy]-2H-1-benzopyran-2-one, C18H16O5
  20. Synthesis and crystal structure of ethyl 4-((4-trifluoromethylbenzyl)amino)benzo, C17H16F3NO2
  21. The crystal structure of (Z)-2-(tert-butyl)-6-(7-(tert-butyl)-5-methylbenzo[d][1,3]oxathiol-2-ylidene)-4-methylcyclohexa-2,4-dien-1-one, C23H28O2S
  22. The crystal structure of (R)-2-aminobutanamide hydrochloride, C4H11ClN2O
  23. Crystal structure of bromido[hydridotris(3-tert-butyl-5-isopropylpyrazolyl)borato-κ3 N,N′,N″]copper(II), C30H52BBrCuN6
  24. Crystal structure of chlorido{hydridotris[3-mesityl-5-methyl-1H-pyrazol-1-yl-κN3]borato}-copper(II) dichloromethane monosolvate
  25. Crystal structure of 4-[3,5-bis(propan-2-yl)-1H-pyrazol-4-yl]pyridine, C14H19N3
  26. Crystal structure of ((4-(4-bromophenyl)-1H-pyrrol-3-yl)methyl)ferrocene, C21H16BrFeNO
  27. Crystal structure of [(4-chlorobenzyl)triphenylphosphonium] dichloridocopper(I), {[C25H21ClP]+[CuCl2]}n
  28. The crystal structure of {Cu(2,9-diisopropyl-4,7-diphenyl-1,10-phenanthroline)[4,5-bis(diphenylphosphino)-9,9-dimethylxanthene]}+ PF6·1.5(EtOAC)
  29. Crystal structure of 3,5-bis(t-butyl)-1H-pyrazol-4-amine, C11H21N3
  30. Crystal structure of [(2,4-dichlorobenzyl)triphenylphosphonium] trichloridocopper(II), [C25H20Cl2P]+[CuCl3]
  31. The crystal structure of dipotassium sulfide, K2S
  32. Crystal structure of (4-(4-methoxyphenyl)-1H-pyrrole-3-carbonyl)ferrocene, C22H19FeNO2
  33. Crystal structure of (E)-6-(4-methylpiperazin-1-yl)-2-(4-(trifluoromethyl)benzylidene)-3, 4-dihydronaphthalen-1(2H)-one, C23H23F3N2O
  34. Crystal structure of (E)-6-morpholino-2-(4-(trifluoromethyl)benzylidene)-3,4-dihydronaphthalen-1(2H)-one, C22H20F3NO2
  35. Crystal structure of Ce9Ir37Ge25
  36. The crystal structure of ethyl 6-(2-nitrophenyl)imidazo[2,1-b]thiazole-3-carboxylate, C14H11N3O4S
  37. Crystal structure of (4-(4-isopropylphenyl)-1H-pyrrol-3-yl)(ferrocenyl)methanone, C24H23FeNO
  38. Crystal structure of bis(methylammonium) tetrathiotungstate(VI), (CH3NH3)2[WS4]
  39. Crystal structure of 6,11-dihydro-12H-benzo[e]indeno[1,2-b]oxepin-12-one, C17H12O2
  40. Crystal structure of 3-[(4-phenylpiperidin-1-yl)methyl]-5-(thiophen-2-yl)-2,3-dihydro-1,3,4- oxadiazole-2-thione, C18H19N3OS2
  41. Crystal structure of N-isopropyl-1,8-naphthalimide C15H13NO2
  42. TiNiSi-type EuPdBi
  43. Crystal structure of 1-(p-tolylphenyl)-4-(2-thienoyl)-3-methyl-1H-pyrazol-5-ol, C16H14N2O2S
  44. The crystal structure of 3-(3-carboxypropyl)-2-nitro-1H-pyrrole 1-oxide, C7H9N3O5
  45. The crystal structure of tetraaqua-bis(2-(2-methyl-5-nitro-1H-imidazol-1-yl)acetato-k2O:N)-tetrakis(2-(2-methyl-5-nitro-1H-imidazol-1-yl)acetato-k1N)trizinc(II) hexahydrate C36H52N18O32Zn3
  46. The crystal structure of 4-(3-carboxy-1-ethyl-6-fluoro-4-oxo-1,4-dihydroquinolin-7-yl)piperazin-1-ium 4-hydroxy-3,5-dimethoxybenzoate monohydrate, C25H30FN3O9
  47. Crystal structure of bis(DL-1-carboxy-2-(1H-indol-3-yl)ethan-1-aminium) oxalate — acetic acid (1/2)
  48. Crystal structure of methyl (E)-4-((4-methylphenyl)sulfonamido)but-2-enoate, C12H15NO4S
  49. The crystal structure of actarit, C10H11NO3
  50. The crystal structure of bicyclol, C19H18O9
  51. The crystal structure of topiroxostat, C13H8N6
  52. Crystal structure of 2,2-dichloro-N-methyl-N-(4-p-tolylthiazol-2-yl)acetamide, C13H12Cl2N2OS
  53. Crystal structure of 4-(trifluoromethyl)-7-coumarinyl trifluoromethanesulfonate C11H4F6O5S
  54. Crystal structure of (1,4,7,10,13,16-hexaoxacyclooctadecane-κ6O6)-((Z)-N,N′-bis(2-(dimethylamino)phenyl)carbamimidato-κ1N)potassium(I)
  55. Crystal structure of (Z)-2-(5-((4-(dimethylamino)naphthalen-1-yl)methylene)-4-oxo-2-thioxothiazolidin-3-yl)acetic acid, C18H16N2O3S2
  56. Crystal structure of (4-fluorobenzyl)triphenylphosphonium bromide, C25H21BrFP
  57. The crystal structure of dichlorido-[6-(pyridin-2-yl)phenanthridine-κ2N, N′]zinc(II)-chloroform (1/1), C19H13N2ZnCl5
  58. Crystal structure of (E)-(3-(2,4-dichlorophenyl)acryloyl)ferrocene, C19H14Cl2FeO
  59. The crystal structure of (E)-7-chloro-1-cyclopropyl-6-fluoro-3-((2-hydroxybenzylidene)amino)quinolin-4(1H)-one, C19H14ClFN2O2
  60. Crystal structure of 2-bromo-11-(((fluoromethyl)sulfonyl)methyl)-6-methyl-6,11-dihydrodibenzo[c,f][1,2]thiazepine 5,5-dioxide, C16H13BrFNO4S2
  61. Crystal structure of 2-chloro-11-(((fluoromethyl)sulfonyl)methyl)-6-methyl-6,11-dihydrodibenzo[c,f][1,2]thiazepine 5,5-dioxide, C16H13ClFNO4S2
  62. Crystal structure of 5-(2,2-difluoropropyl)-5-methyl-6-oxo-5,6-dihydrobenzo[4,5]imidazo[2,1-a]isoquinoline-3-carbonitrile, C20H15F2N3O
Heruntergeladen am 2.10.2025 von https://www.degruyterbrill.com/document/doi/10.1515/ncrs-2025-0121/html
Button zum nach oben scrollen